Literature DB >> 17005163

Peripheral injection of CCK-8S induces Fos expression in the dorsomedial hypothalamic nucleus in rats.

Peter Kobelt1, Stephan Paulitsch, Miriam Goebel, Andreas Stengel, Marco Schmidtmann, Ivo R van der Voort, Johannes J Tebbe, Rüdiger W Veh, Burghard F Klapp, Bertram Wiedenmann, Yvette Taché, Hubert Mönnikes.   

Abstract

Peripheral cholecystokinin (CCK) plays a physiological role in the regulation of food intake. The dorsomedial hypothalamic nucleus (DMH) has been implicated in the brain regulation of food intake and satiety. The aim of this study was to determine if peripherally administered CCK affects neuronal activity in the DMH, as assessed by Fos expression. Density of Fos-positive neurons was determined in the DMH, paraventricular nucleus of the hypothalamus (PVN), arcuate nucleus of the hypothalamus (ARC) and ventromedial hypothalamic nucleus (VMH) in non-fasted Sprague-Dawley rats in response to intraperitoneally (ip) injection of CCK-8S (2 microg/kg, n=6) or vehicle (0.15 M NaCl; n=6). CCK-8S increased Fos immunoreactivity in the DMH (mean+/-SEM; cells/section: 108+/-10 versus 54+/-6, p<0.001) and PVN (120+/-12 versus 20+/-3, p<0.001) compared to the vehicle group while not influencing Fos expression in the ARC and VMH. Double labeling showed that 27.4+/-6.4% (n=3) of Fos-positive neurons induced by CCK-8S were positive for corticotropin-releasing factor immunoreactivity, that were mainly localized in the ventral part of the DMH, and encircled in a network of tyrosine-hydroxylase-immunoreactive positive fibers. These data indicate that in addition of the PVN, peripheral CCK increases neuronal activity in the DMH suggesting a possible role in this hypothalamic nucleus in the satiating effect of the peptide.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005163     DOI: 10.1016/j.brainres.2006.08.092

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Medial dorsal hypothalamus mediates the inhibition of reward seeking after extinction.

Authors:  Nathan J Marchant; Teri M Furlong; Gavan P McNally
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

2.  Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway.

Authors:  Jin Zhou; Zi-Xiang Zhang; De-Chun Li
Journal:  Curr Ther Res Clin Exp       Date:  2010-08

3.  The Combination of Cholecystokinin and Stress Amplifies an Inhibition of Appetite, Gastric Emptying, and an Increase in c-Fos Expression in Neurons of the Hypothalamus and the Medulla Oblongata.

Authors:  Naomi Yamaguchi; Eriko Hosomi; Yutaro Hori; Shoki Ro; Kosuke Maezawa; Mitsuko Ochiai; Sumiko Nagoshi; Kiyoshige Takayama; Koji Yakabi
Journal:  Neurochem Res       Date:  2020-07-14       Impact factor: 3.996

Review 4.  The hypothalamus and the neurobiology of drug seeking.

Authors:  Nathan J Marchant; E Zayra Millan; Gavan P McNally
Journal:  Cell Mol Life Sci       Date:  2011-09-23       Impact factor: 9.261

Review 5.  Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Curr Protein Pept Sci       Date:  2011-06       Impact factor: 3.272

Review 6.  An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus.

Authors:  Philip L Johnson; Anantha Shekhar
Journal:  Physiol Behav       Date:  2012-03-26

7.  Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents.

Authors:  Peter Kobelt; Anna-Sophia Wisser; Andreas Stengel; Miriam Goebel; Norbert Bannert; Guillaume Gourcerol; Tobias Inhoff; Steffen Noetzel; Bertram Wiedenmann; Burghard F Klapp; Yvette Taché; Hubert Mönnikes
Journal:  Peptides       Date:  2008-02-07       Impact factor: 3.750

8.  Interactions of gastrointestinal peptides: ghrelin and its anorexigenic antagonists.

Authors:  Anna-Sophia Wisser; Piet Habbel; Bertram Wiedenmann; Burghard F Klapp; Hubert Mönnikes; Peter Kobelt
Journal:  Int J Pept       Date:  2010-01-06

9.  Characterization of the feeding inhibition and neural activation produced by dorsomedial hypothalamic cholecystokinin administration.

Authors:  J Chen; K A Scott; Z Zhao; T H Moran; S Bi
Journal:  Neuroscience       Date:  2008-03-03       Impact factor: 3.590

10.  Peripheral injection of ghrelin induces Fos expression in the dorsomedial hypothalamic nucleus in rats.

Authors:  Peter Kobelt; Anna-Sophia Wisser; Andreas Stengel; Miriam Goebel; Tobias Inhoff; Steffen Noetzel; Rüdiger W Veh; Norbert Bannert; Ivo van der Voort; Bertram Wiedenmann; Burghard F Klapp; Yvette Taché; Hubert Mönnikes
Journal:  Brain Res       Date:  2008-02-02       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.